prostate-report.org

Using finasteride and dutasteride to prevent prostate cancer

A recent study at Memorial Sloan-Kettering Cancer Center has reanalyzed data regarding Prostate Cancer Prevention Trial  (PCPT) to see if it is possible to address this problem.

The authors state two conclusions:

• Clinicians wishing to reduce the risk of any biopsy-detectable prostate cancer should recommend finasteride to all men.
• Clinicians who believe that it is unnecessary to prevent all cancers, but that preventing those readily detectable by screening would be desirable, would be best off recommending finasteride only to a high-risk subgroup.